The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics.  Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay.  Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics.  We profile 58 companies, large and small, working in this area.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report.  Your credit card order sends the report to your inbox instantly.  Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges. 

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.